A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/06/1998	US5817752 Halogenation of serine, cyclizing by reacting halo group with mercapto group of cysteine
10/06/1998	US5817750 Structural mimics of RGD-binding sites
10/06/1998	US5817749 Cyclic pentapeptides
10/06/1998	US5817635 Rna molecules with catalytic activity
10/06/1998	US5817632 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/06/1998	US5817631 Therapeutic uses of melanin
10/06/1998	US5817630 Glutathione antioxidant eye drops
10/06/1998	US5817629 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
10/06/1998	US5817628 Dynorphin a suppression of natural killer cell activity
10/06/1998	US5817627 Long-acting galenical formulation for GRF peptides
10/06/1998	US5817626 Modulators of beta-amyloid peptide aggregation
10/06/1998	US5817625 Methods of prevention of oral mucositis with transforming growth factor beta
10/06/1998	US5817624 Permeation enhancer compositions for increased absorption of therapeutic proteins through the colonic membrane
10/06/1998	US5817622 Cloning dna sequences
10/06/1998	US5817621 Skin disorders
10/06/1998	US5817619 Viricides
10/06/1998	US5817618 Protein isolated from mussels, glycogen
10/06/1998	US5817617 Selectin and pertussis toxin derived peptides and uses thereof
10/06/1998	US5817515 Human B2 integrin alpha subunit antibodies
10/06/1998	US5817513 Immunotherapy for cancer
10/06/1998	US5817511 Nucleotide sequence coding for variable regions of the α chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
10/06/1998	US5817501 DNA encoding suppressin protein and uses thereof
10/06/1998	US5817497 Glutathione s-transferase
10/06/1998	US5817496 Kynurenine aminotransferase
10/06/1998	US5817494 Anticancer agents; viricides
10/06/1998	US5817493 Lipases immobilized in sol-gel processed hydrophobic materials
10/06/1998	US5817491 Enveloped vector particle; vesicular stomatitis virus
10/06/1998	US5817486 Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides
10/06/1998	US5817485 Nucleic acids and cells for recombinant production of fibroblast growth factor-10
10/06/1998	US5817482 Disease related nucleotide kinases
10/06/1998	US5817481 Medical diagnosis; detecting diseases related to mutants in nucleic acid sequences and altered concentration of polypeptides
10/06/1998	US5817480 DNA encoding a histamine H2 receptor
10/06/1998	US5817477 Adrenergic receptor
10/06/1998	US5817476 Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
10/06/1998	US5817471 Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor
10/06/1998	US5817343 Method for fabricating polymer-based controlled-release devices
10/06/1998	US5817327 Incorporation of biologically active molecules into bioactive glasses
10/06/1998	US5817316 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding
10/06/1998	US5817313 Monoclonal antibodies and conjugates thereof useful for the treatment of cancer
10/06/1998	US5817312 Sprayable immunoglobulins
10/06/1998	US5817311 Graft verses host disease, transplant rejection
10/06/1998	US5817310 Human platelet derived growth factor
10/06/1998	US5817309 Antidote for hirudin and synthetic thrombin inhibitors and method of use
10/06/1998	US5817308 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
10/06/1998	US5817307 Bactericides
10/06/1998	US5817306 Method for treating graft versus host disease
10/06/1998	US5817305 Anti-inflammatory compositions and methods
10/06/1998	US5817303 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
10/06/1998	CA2168131C Tetrahydro-1h-benzazepinones containing acid surrogates
10/06/1998	CA2086631C Oral administration of immunologically active biomolecules and other therapeutic proteins
10/06/1998	CA2082824C Pseudomonas exotoxin multifunctional fusion proteins having carboxyl alterations with increased cytotoxicity
10/06/1998	CA1340077C ¬ser 17, leu 18\|grf derivatives
10/04/1998	CA2233797A1 Pharmaceutical product for application to uterus mucosa
10/02/1998	CA2233787A1 Sialoadhesin family member-3
10/02/1998	CA2233785A1 Tumor necrosis related receptor, tr7
10/02/1998	CA2232743A1 A tnf homologue, tl5
10/02/1998	CA2226910A1 Sialoadhesin family member-2 (saf-2)
10/02/1998	CA2223021A1 Novel human neurotensin receptor type 2 and splice variants thereof
10/01/1998	WO1998043182A1 Coincidence detection method, products and apparatus
10/01/1998	WO1998043095A1 Liposomes containing oligonucleotides
10/01/1998	WO1998043089A1 Monoclonal antibodies to human cd6
10/01/1998	WO1998042868A2 Screening method for proline-rich proteins
10/01/1998	WO1998042862A1 Iron-casein complex hydrolyzate and process for the production thereof
10/01/1998	WO1998042861A1 Process for preparing obesity protein analogs
10/01/1998	WO1998042855A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors
10/01/1998	WO1998042850A1 Anticoagulant fusion protein anchored to cell membrane
10/01/1998	WO1998042849A1 Keratinocyte derived kallikrein
10/01/1998	WO1998042847A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
10/01/1998	WO1998042841A1 Interferon related protein hkafe42
10/01/1998	WO1998042840A1 Motilin homologs
10/01/1998	WO1998042839A1 Human rab protein, srab
10/01/1998	WO1998042837A1 Human mitochondrial chaperone protein
10/01/1998	WO1998042835A1 Human genes
10/01/1998	WO1998042834A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	WO1998042833A2 Kv potassium channel polypeptides and polynucleotides
10/01/1998	WO1998042830A2 Noey2 gene compositions and methods of use
10/01/1998	WO1998042824A2 Methods for selecting cells and their uses
10/01/1998	WO1998042753A1 Novel antiplatelet agent
10/01/1998	WO1998042752A1 Immunotherapeutic ctla-4 binding peptides
10/01/1998	WO1998042751A1 Oxidised fragments of apolipoprotein b and their use
10/01/1998	WO1998042750A1 ANTIGENIC FUSIONPROTEIN CARRYING GALα1,3GAL EPITOPES
10/01/1998	WO1998042749A1 Zinc free insulin crystals for use in pulmonary compositions
10/01/1998	WO1998042748A1 New synthetic polypeptide
10/01/1998	WO1998042747A1 Polypeptide with appetite regulating activity
10/01/1998	WO1998042746A2 Synthetic saposin c-derived neurotrophic peptides
10/01/1998	WO1998042745A1 Iron-casein complex and process for preparing the same
10/01/1998	WO1998042744A1 Protein inhibiting cell death
10/01/1998	WO1998042742A1 Vp22 proteins and uses thereof
10/01/1998	WO1998042741A2 Secreted proteins and polynucleotides encoding them
10/01/1998	WO1998042740A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection
10/01/1998	WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042737A2 Peptides for the treatment of systemic lupus erythematosus
10/01/1998	WO1998042735A1 Novel monomer elements for marking peptidic nucleic acids
10/01/1998	WO1998042734A1 Process of purification of cyclosporin
10/01/1998	WO1998042733A1 uPAR MIMICKING PEPTIDE
10/01/1998	WO1998042732A1 Mu-opiate receptor peptides
10/01/1998	WO1998042726A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998	WO1998042725A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998	WO1998042724A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

1 ... 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 ... 3163